ADMA BIOLOGICS, INC. (ADMA)
ADMA INVESTOR DEADLINE: ADMA Biologics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
ADMA INVESTOR DEADLINE: ADMA Biologics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
Alpha Cash Regulatory Footprint Expands to Six States, Reaching an Estimated 2.4 Million Unbanked and Underbanked Households
ParaZero Receives Additional DefendAir Net Pod Order from Second Business Unit of Tier-1 Israeli-Based Global Defense Company
Smartbird Appoints New CEO to Advance AI Infrastructure Strategy
A New Press Release from Elicio Therapeutics
Europe Recognizes Nature-Based Plant Improvement, Opening a New Pathway for Cibus
StepStone and PitchBook Launch Deal-Level Benchmarking Solution, Adding StepStones Institutional-Grade Fund and Deal Performance Data to PitchBooks Private Markets Intelligence
Ameresco Modernizes Energy Infrastructure Across Mount Sinai School District
IonQ Introduces Clavis XG Multiplex, Making Quantum Security Deployable at Scale in Metro Networks
Stem Launches AIONA, a Dedicated AI Services Offering Built for Operational Impact